In the latest session, DocGo Inc (NASDAQ: DCGO) closed at $3.78 down -0.79% from its previous closing price of $3.81. In other words, the price has decreased by -$0.0300 from its previous closing price. On the day, 831496 shares were traded. DCGO stock price reached its highest trading level at $3.8950 during the session, while it also had its lowest trading level at $3.6900.
Ratios:
For a deeper understanding of DocGo Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.99 and its Current Ratio is at 1.99. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on August 18, 2023, initiated with a Buy rating and assigned the stock a target price of $15.
On April 21, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.
On April 19, 2022, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $11.Deutsche Bank initiated its Buy rating on April 19, 2022, with a $11 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 15 ’24 when KATZ STEVEN bought 13,500 shares for $3.64 per share. The transaction valued at 49,140 led to the insider holds 69,534 shares of the business.
ROSENBERG NORMAN bought 10,000 shares of DCGO for $36,100 on Mar 14 ’24. The CFO and Treasurer now owns 274,222 shares after completing the transaction at $3.61 per share. On Mar 14 ’24, another insider, Burdiek Michael J, who serves as the Director of the company, bought 10,000 shares for $3.61 each. As a result, the insider paid 36,100 and bolstered with 571,595 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DCGO now has a Market Capitalization of 393.77M and an Enterprise Value of 380.98M. As of this moment, DocGo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 58.24, and their Forward P/E ratio for the next fiscal year is 8.09. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.87. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.63 while its Price-to-Book (P/B) ratio in mrq is 1.31. Its current Enterprise Value per Revenue stands at 0.61 whereas that against EBITDA is 12.10.
Stock Price History:
Over the past 52 weeks, DCGO has reached a high of $10.82, while it has fallen to a 52-week low of $2.78. The 50-Day Moving Average of the stock is 3.7302, while the 200-Day Moving Average is calculated to be 5.9605.
Shares Statistics:
For the past three months, DCGO has traded an average of 1.62M shares per day and 517.58k over the past ten days. A total of 104.06M shares are outstanding, with a floating share count of 86.44M. Insiders hold about 17.02% of the company’s shares, while institutions hold 46.82% stake in the company. Shares short for DCGO as of Mar 15, 2024 were 9.91M with a Short Ratio of 6.11, compared to 9.84M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 9.51% and a Short% of Float of 10.90%.
Earnings Estimates
There are 7 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.08 for the current quarter, with a high estimate of $0.11 and a low estimate of $0.05, while EPS last year was -$0.03. The consensus estimate for the next quarter is $0.08, with high estimates of $0.11 and low estimates of $0.06.
Analysts are recommending an EPS of between $0.46 and $0.25 for the fiscal current year, implying an average EPS of $0.34. EPS for the following year is $0.47, with 5 analysts recommending between $0.58 and $0.34.
Revenue Estimates
A total of 7 analysts believe the company’s revenue will be $187.93M this quarter.It ranges from a high estimate of $202.9M to a low estimate of $181.52M. As of the current estimate, DocGo Inc’s year-ago sales were $111.53M, an estimated increase of 68.50% from the year-ago figure. For the next quarter, 7 analysts are estimating revenue of $185.29M, an increase of 47.70% less than the figure of $68.50% in the same quarter last year. There is a high estimate of $206.3M for the next quarter, whereas the lowest estimate is $172.6M.
A total of 7 analysts have provided revenue estimates for DCGO’s current fiscal year. The highest revenue estimate was $803.6M, while the lowest revenue estimate was $728.2M, resulting in an average revenue estimate of $745.2M. In the same quarter a year ago, actual revenue was $624.29M, up 19.40% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $809.07M in the next fiscal year. The high estimate is $834.1M and the low estimate is $761M. The average revenue growth estimate for next year is up 8.60% from the average revenue estimate for this year.
